Nonuniform absorbed dose distribution in the kidney: The influence of organ architecture

Cancer Biotherapy and Radiopharmaceuticals

Volumn 19, Issue 3, 2004, Pages 371-377

  Green, Alan ^a   Flynn, Aiden ^a   Pedley, R Barbara ^a   Dearling, Jason ^a   Begent, Richard ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antibody; Kidney; Radioimmunotherapy; Radionuclide dosimetry

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IODINE 125; IODINE 131; RADIOISOTOPE; RHENIUM 186; TUMOR ANTIGEN; YTTRIUM 90;

CALCULATION; CANCER RADIOTHERAPY; HUMAN; KIDNEY CORTEX; KIDNEY MEDULLA; MATHEMATICAL MODEL; MOLECULAR WEIGHT; NEPHROTOXICITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOIMMUNOTHERAPY; RADIOISOTOPE THERAPY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; URINARY EXCRETION;

ANIMALS; ANTIBODIES; COLORECTAL NEOPLASMS; HUMANS; KIDNEY; MICE; NEOPLASM TRANSPLANTATION; RADIATION DOSAGE; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOTHERAPY, COMPUTER-ASSISTED;

EID: 3142751242     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/1084978041425052     Document Type: Review

References (11)

1. Bouchet LG, Bolch WE, Blanco HP, et al. MIRD pamphlet no. 19: Absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. J Nucl Med 2003;44:1113.
2. Lane DM, Eagle KF, Begent RHJ, et al. Radioimmunotherapy of metastatic colorectal tumors with iodine-131-labeled antibody to carcinoembryonic antigen-phase I/II study with comparative biodistribution of intact and F(Ab′)(2) antibodies. Br J Cancer 1994;70:521.
3. Pedley RB, Boden JA, Boden R, et al. Comparative radioimmunotherapy using intact F(Ab′)2 fragments of I-131 anti-Cea antibody in a colonic xenograft model. Br J Cancer 1993;68:69.
4. Press OW, Eary JF, Appelbaum FR, et al. Phase-II trial of I-131 B1 (Anti-Cd20) antibody therapy with autologous stem-cell transplantation for relapsed B-cell lymphomas. Lancet 1995;346:336.
5. Stein R, Juweid M, Mattes MJ, et al. Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: Antibody processing, targeting, and experimental therapy with I-131 and Y-90 labeled MAbs. Cancer Biother & Radiopharm 1999; 14:37.
6. Harwood PJ, Britton DW, Southall PJ, et al. Mapping epitope characteristics on carcinoembryonic antigen. Br J Cancer 1986;54:75.
7. Casey JL, King DJ, Chaplin LC, et al. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab′ fragments. Br J Cancer 1996;74:1397.
8. Chester KA, Begent RHJ, Robson L, et al. Phage libraries for generation of clinically useful antibodies. Lancet 1994;343:455.
9. Flynn AA, Pedley RB, Green AJ, et al. The nonuniformity of antibody distribution in the kidney and its influence on dosimetry. Radiat Res 2003;159:182.
10. Flynn AA, Green AJ, Boxer G et al. A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology. Phys Med Biol 1999;44:N151.
11. Berger MJ. Distribution of Absorbed Dose Around Point Sources of Electrons and Beta Particles in Water and Other Media. Reston, VA: Society of Nuclear Medicine, 1971.